Identifying and moving levers of acceptance and uptake of recommended quality-assured paediatric ACTs for non-complicated malaria
Abstract
This study is built on an analysis of six francophone countries in West and Central Africa to determine the most critical barriers to the acceptance and uptake of recommended quality assured drugs for the treatment of malaria in children. Borrowing from a WHO-endorsed framework to assess barriers to essential medicines, it draws out common themes across all the target countries and makes recommendations for interventions which could remove some of the more critical barriers to acceptance and uptake of new therapies for the treatment of malaria in children.
Citation
Camus-Bablon, F. Identifying and moving levers of acceptance and uptake of recommended quality-assured paediatric ACTs for non-complicated malaria. (2012) 38 pp.
Links
Published 1 January 2012